| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 01/20/2000 | CA2333898A1 Chemotaxis-inhibiting protein of staphylococcus (chips) and its use |
| 01/20/2000 | CA2333893A1 Delta cleavage products and methods based thereon |
| 01/20/2000 | CA2332625A1 Interaction of human beta amyloid precursor protein (.beta.-app) with human lon-protease like protein (hslon) |
| 01/20/2000 | CA2332307A1 Human transport protein homologs |
| 01/20/2000 | CA2331789A1 Cancer treatment methods using therapeutic conjugates that bind to aminophospholipids |
| 01/19/2000 | EP0972840A2 New attenuated myxoma recombinant virus and its use in the preparation of mixed vaccines against myxomatosis and rabbit hemorrhagic disease |
| 01/19/2000 | EP0972839A1 Insertional mutations in mycobacteria |
| 01/19/2000 | EP0972837A2 Ubiquitin specific protease like protein |
| 01/19/2000 | EP0972828A1 Process for the in vitro replication of HCV |
| 01/19/2000 | EP0972782A1 Monoclonal antibody which recognizes the oligosaccharide n-glycolylated-galactose-glucose sialic acid in malignant tumors, and composition containing it |
| 01/19/2000 | EP0972528A2 Radioimmunoconjugate for use in human therapy and its preparation |
| 01/19/2000 | EP0972523A2 Method and compositions for inducing immunity to viruses |
| 01/19/2000 | EP0972521A1 Pharmaceutical composition containing stimulators of interferon-gamma |
| 01/19/2000 | EP0972519A1 Immune tolerance inducers |
| 01/19/2000 | EP0972518A2 Exchange of T lymphocytes |
| 01/19/2000 | EP0972200A1 Screening and treatment using complement regulator or receptor proteins |
| 01/19/2000 | EP0972055A1 Method for producing purified and optionally marked tsh receptor preparations, radioiodized tsh receptor preparations and the use of preparations of this type in diagnostics and therapy |
| 01/19/2000 | EP0972054A1 Enhancement of immune response using targeting molecules |
| 01/19/2000 | EP0972053A1 Novel human serine carboxypeptidase |
| 01/19/2000 | EP0972052A1 Keratinocyte derived kallikrein |
| 01/19/2000 | EP0972048A1 Recombinant proteins of a pakistani strain of hepatitis e and their use in diagnostic methods and vaccines |
| 01/19/2000 | EP0972047A2 Papilloma virus main capsid protein and the use thereof in diagnosis, therapy and vaccination |
| 01/19/2000 | EP0972045A1 NUCLEIC ACID FRAGMENTS AND POLYPEPTIDE FRAGMENTS DERIVED FROM $i(M. TUBERCULOSIS) |
| 01/19/2000 | EP0972040A1 Human gtp binding protein |
| 01/19/2000 | EP0972038A1 Human tumorigenesis associated protein, htap |
| 01/19/2000 | EP0972036A2 Prion propagation inhibition by dominant-negative prion protein mutants |
| 01/19/2000 | EP0972028A1 Vascular endothelial growth factor c (vegf-c) protein and gene, mutants thereof, and uses thereof |
| 01/19/2000 | EP0972027A1 Human c5a-like receptor |
| 01/19/2000 | EP0972021A1 Extracellular/epidermal growth factor like protein |
| 01/19/2000 | EP0971959A1 Humanized antibodies and methods for forming humanized antibodies |
| 01/19/2000 | EP0971945A1 Uronium salt conjugate vaccines |
| 01/19/2000 | EP0971741A1 Use of avian antibodies |
| 01/19/2000 | EP0971740A2 Fibronectin binding protein compositions, antibodies thereto, and methods of use |
| 01/19/2000 | EP0971739A2 Aqueous immunologic adjuvant compositions of monophosphoryl lipid a |
| 01/19/2000 | EP0971738A1 Detoxified mutants of bacterial adp-ribosylating toxins as parenteral adjuvants |
| 01/19/2000 | EP0971737A1 Immunopotentiating formulations for vaccinal use |
| 01/19/2000 | EP0971736A1 Pharmaceutical compositions comprising a polynucleotide and optionally an antigen especially for vaccination |
| 01/19/2000 | EP0971735A1 Methods and compositions for treating inflammatory bowel disease |
| 01/19/2000 | EP0971734A1 Carbohydrate antigens which immunoreact with polyclonal antisera against h. pylori |
| 01/19/2000 | EP0971733A1 A composition comprising a carrier and a purified mycobacterial lipid cell-wall component and its use in the prevention, treatment and diagnosis of disease |
| 01/19/2000 | EP0971727A1 Production process for intravenous immune serum globulin and resultant product |
| 01/19/2000 | EP0971726A1 Peptides for inhibiting retroviruses |
| 01/19/2000 | EP0971712A1 Compositions for the inhibition of bone resorption |
| 01/19/2000 | EP0971703A1 Use of microparticles having a protein and an antibody adsorbed thereon for preparing a pharmaceutical composition for intranasal administration |
| 01/19/2000 | EP0971696A1 Thimerosal-free preservatives for vaccines |
| 01/19/2000 | EP0971693A2 Method of making microencapsulated dna for vaccination and gene therapy |
| 01/19/2000 | EP0971692A2 Specific magnetosome, method for the production and use thereof |
| 01/19/2000 | EP0654086B1 Vaccines against aujeszky's disease and other animal diseases containing pseudorabies virus mutants |
| 01/19/2000 | EP0625989B1 Dna sequences encoding novel growth/differentiation factors |
| 01/19/2000 | EP0587873B1 Process for the production of cells infected by a multiple sclerosis associated virus |
| 01/19/2000 | CN1242045A Immunotherapy and improved vaccines |
| 01/19/2000 | CN1241906A Adjuvant for transcutaneous immunization |
| 01/19/2000 | CN1241632A Gene engineering adenovirus and its application |
| 01/19/2000 | CN1241573A Liver cancer murine monoclone antibody without endogenous immunoglobulin and its preparation and application |
| 01/19/2000 | CN1048523C Method for preparing viral protein generated from hepatitisvirokine |
| 01/18/2000 | US6015889 Protein rib, a cell surface protein that confers immunity to many strains of the group B streptococcus: process for purification of the protein, reagent kit and pharmaceutical composition |
| 01/18/2000 | US6015884 Soluble divalent and multivalent heterodimeric analogs of proteins |
| 01/18/2000 | US6015882 Amino acid sequence of antigen gp900 detected at the surface of cryptosporidium sporozoites or merozoites; for antiprotozoa agents |
| 01/18/2000 | US6015795 Bovine viral diarrhea virus II vaccine and method of immunization |
| 01/18/2000 | US6015790 Methods and compositions for treating rheumatoid arthritis |
| 01/18/2000 | US6015701 N-acetylglucosaminyltransferase V proteins and coding sequences |
| 01/18/2000 | US6015696 Mycobacterium bovis bcg that has been transformed with a vector comprising a promoter, a signal sequence, a dna sequence encoding a heterologous polypeptide, and a replicator region; for vaccines |
| 01/18/2000 | US6015695 Immunoglobulins devoid of light chains |
| 01/18/2000 | US6015688 Transferrin receptor genes |
| 01/18/2000 | US6015680 Human lung adenocarcinoma-related monoclonal antibody and immunoassay method which uses the same |
| 01/18/2000 | US6015669 Identification of genes |
| 01/18/2000 | US6015660 Borna disease viral sequences, diagnostics and therapeutics for nervous system diseases |
| 01/18/2000 | US6015576 Method for inducing a systemic immune response to an antigen |
| 01/18/2000 | US6015572 Glial cells with neurotropic factors for nerve damage |
| 01/18/2000 | US6015567 HER2 extracellular domain |
| 01/18/2000 | US6015566 Peptide composition generating an immune response against herpes virus |
| 01/18/2000 | US6015564 Polypeptides with fatty acid and steroids |
| 01/18/2000 | US6015563 Polyphosphazene polyelectrolyte immunoadjuvants |
| 01/18/2000 | US6015558 Treatment of insulin resistance in obesity linked type II diabetes using antagonists to TNF-α function |
| 01/18/2000 | US6015556 Cytotoxic drug therapy |
| 01/18/2000 | US6015554 Method of reconstituting human lymphoid and dendritic cells |
| 01/18/2000 | CA2132199C Depsipeptide derivative, production thereof and use thereof |
| 01/18/2000 | CA2012895C Recombinant cytomegalovirus vaccine |
| 01/18/2000 | CA2006587C Membrane proteins and peptides of haemophilus influenzae type b |
| 01/18/2000 | CA1340876C The vp7 gene of human rotavirus 4 |
| 01/13/2000 | WO2000002051A1 Trifunctional reagent for conjugation to a biomolecule |
| 01/13/2000 | WO2000002050A1 Trifunctional reagent for conjugation to a biomolecule |
| 01/13/2000 | WO2000001825A1 HELICOBACTER ANTIGEN (η-GLUTAMYLTRANSPEPTIDASE) AND SEQUENCES ENCODING THE SAME |
| 01/13/2000 | WO2000001823A2 Flt3-l mutants and methods of use |
| 01/13/2000 | WO2000001822A1 Specific binding proteins including antibodies which bind to the necrotic centre of tumours, and uses thereof |
| 01/13/2000 | WO2000001811A1 Kv6.2, A VOLTAGE-GATED POTASSIUM CHANNEL SUBUNIT |
| 01/13/2000 | WO2000001728A1 Galectin 11 |
| 01/13/2000 | WO2000001419A1 Drug complex for treatment of metastatic prostate cancer |
| 01/13/2000 | WO2000001410A1 Methods of inhibiting proliferative diseases by inhibiting tgf-beta mediated angiogenesis |
| 01/13/2000 | WO2000001409A2 Porcine circovirus and parvovirus vaccine |
| 01/13/2000 | WO2000001408A2 Haemophilus parasuis vaccine and diagnostic |
| 01/13/2000 | WO2000001345A2 Use of an amphipathic compound for providing an adjuvant to a subunit vaccine |
| 01/13/2000 | WO1999060135A8 Generation of multiple gene products from chimeric fusion proteins by cleavage with ubiquitous endoproteases |
| 01/13/2000 | WO1999060125A3 Secreted proteins |
| 01/13/2000 | WO1999059628A3 Combination therapy for the treatment of tumors |
| 01/13/2000 | WO1999058118A3 METHODS FOR REGULATING HEMATOPOIESIS USING CpG-OLIGONUCLEOTIDES |
| 01/13/2000 | WO1999057241A3 Myelin basic protein peptides and uses thereof |
| 01/13/2000 | WO1999055312A3 Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces |
| 01/13/2000 | WO1999053953A3 Methods and products related to metabolic interactions in disease |
| 01/13/2000 | WO1999053950A3 Live vaccines and methods of treatment therewith |